Replies to post #556 on Phio Pharmaceuticals Corp (PHIO)

[The Night Stalker]

what are you talking about? insiders are buying this up


New insider filings for RXII: RXi Pharmaceuticals Corp

Director: Bitterman Robert J Acquired 500,000 Stock Option (right to buy) (Derivative security at conversion or exercise price: $0.200) on Jun 7, 13. Direct holding 500,000 shares/units after transaction. Stock Option (right to buy) expires on Jun 7, 23. Director: Brownlie Keith L Acquired 500,000 Stock Option (right to buy) (Derivative security at conversion or exercise price: $0.200) on Jun 7, 13. Direct holding 500,000 shares/units after transaction. Stock Option (right to buy) expires on Jun 7, 23. First-Class Insider (President & CEO):CAUWENBERGH GEERT Acquired 4,000,000 Stock Option (right to buy) (Derivative security at conversion or exercise price: $0.200) on Jun 7, 13. Direct holding 4,000,000 shares/units after transaction. Stock Option (right to buy) expires on Jun 7, 23. Senior Officer (Secretary & Controller): Kontulis Caitlin Acquired 300,000 Stock Option (right to buy) (Derivative security at conversion or exercise price: $0.200) on Jun 7, 13. Direct holding 300,000 shares/units after transaction. Stock Option (right to buy) expires on Jun 7, 23. Senior Officer (Chief Development Officer): Pavco Pamela Acquired 2,000,000 Stock Option (right to buy) (Derivative security at conversion or exercise price: $0.200) on Jun 7, 13. Direct holding 2,000,000 shares/units after transaction. Stock Option (right to buy) expires on Jun 7, 23.